The chip maker invested about $100 million in OpenAI's latest funding round, The Wall Street Journal reports. The CEO will need to convince investors that the company is still more than an auto maker.

The announcement could shake up the market for such injections, since the shortage designation allowed compounding pharmacies ...

The FDA declared the end to shortages of Zepbound and Mounjaro. That could mean new restrictions on pharmacies making ...

The Food and Drug Administration declared an end to the scarcity of Eli Lilly's highly in-demand weight-loss and diabetes ...

You can blow the minds of young people by telling them about Blockbuster Video. Thanks to Netflix the idea of going to a shop ...

More than 1.6 million Britons are set to get the 'King Kong' of fat jabs on the NHS over the next 12 years.

More than 1.6 million Britons are set to get the ‘King Kong’ of fat jabs on the NHS over the next 12 years. Mounjaro – which ...

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

FDA称，礼来两款替尔泊肽成分GLP-1注射剂Zepbound和Mounjaro 2022年来一直因需求增长而供应短缺，现认定短缺问题解决。行业组织称，FDA的认定等于让药房停止配置和分发两款药的仿制药。

Ozempic and other diabetes-weight loss drugs have been linked to at least 162 deaths and 10,000 cases involving “serious” ...

当地时间2号，美国食品和药物管理局网站显示，礼来公司的减肥药在美国已不再短缺。美国食品和药物管理局说，以治疗糖尿病的Mounjaro和控制体重的Zepbound名义销售的所有剂量的药物——替扎帕肽——的短缺问题已经解决。该机构说，随着产品在供应链中的流动，患者和处方者仍可能偶尔遇到局部短缺。礼来公司没有立即回应路透 ...